Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome-Reference-Cited by-同舟云学术

Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome

Published:2021-03-16 Issue: Volume: Page:
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discov

Author:

Liudahl Shannon M.^ORCID,Betts Courtney B.,Sivagnanam Shamilene,Morales-Oyarvide Vicente,da Silva Annacarolina^ORCID,Yuan Chen^ORCID,Hwang Samuel,Grossblatt-Wait Alison,Leis Kenna R.,Larson William,Lavoie Meghan B.,Robinson Padraic,Dias Costa Andressa,Väyrynen Sara A.,Clancy Thomas E.,Rubinson Douglas A.^ORCID,Link Jason,Keith Dove^ORCID,Horton Wesley,Tempero Margaret A.^ORCID,Vonderheide Robert H.^ORCID,Jaffee Elizabeth M.^ORCID,Sheppard Brett,Goecks Jeremy,Sears Rosalie C.,Park Byung S.^ORCID,Mori Motomi,Nowak Jonathan A.,Wolpin Brian M.,Coussens Lisa M.^ORCID

Funder

HHS | National Institutes of Health

Orionin Tutkimussäätiö

Stand Up To Cancer

Lustgarten Foundation

Pancreatic Cancer Action Network

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational methods and biomarker discovery strategies for spatial proteomics: a review in immuno-oncology;Briefings in Bioinformatics;2024-07-25

2. Panoramic tumor microenvironment in pancreatic ductal adenocarcinoma;Cellular Oncology;2024-07-15

3. Spatial Heterogeneity of Immune Regulators Drives Dynamic Changes in Local Immune Responses, Affecting Disease Outcomes in Pancreatic Cancer;Clinical Cancer Research;2024-07-15

4. Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor;Cancer Immunology Research;2024-07-11

5. The preclinical gap in pancreatic cancer and radiotherapy;Disease Models & Mechanisms;2024-07-01